Nazione: Unione Europea
Lingua: italiano
Fonte: EMA (European Medicines Agency)
Istradefylline
Kyowa Kirin Holdings B.V.
N04
istradefylline
Farmaci anti-Parkinson
Morbo di Parkinson
Istradefylline is indicated in adults as an adjunctive treatment to levodopa based regimens in patients with Parkinson’s disease (PD) experiencing “OFF” time.
rifiutato